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Abstract
Background: Computed tomographic pulmonary angiography (CTPA) is increasingly being used as first
investigation for suspected pulmonary embolism (PE). The investigation has high predictive value, but is resource
and time intensive and exposes patients to considerable radiation. Our aim was to assess the potential value of a
negative d-dimer assay to exclude pulmonary emboli and reduce the number of performed CTPAs.
Methods: All CTPAs performed in a Scottish secondary care hospital for a fourteen month period were
retrospectively reviewed. Collected data included the presence or absence of PE, d-dimer results and patient
demographics. PE positive CTPAs were reviewed by a specialist panel.
Results: Pulmonary embolisms were reported for 66/405 (16.3%) CTPAs and d-dimer tests were performed for 216
(53%). 186/216 (86%) patients had a positive and 30 (14%) a negative d-dimer result. The panel agreed 5/66 (7.6%)
false positive examinations. The d-dimer assay’s negative predictive value was 93.3% (95% CI = 76.5%-98.8%) based
on the original number of positive CTPAs and 100% (95% CI = 85.9%-100%) based on expert review. Significant non-
PE intrapulmonary pathology was reported for 312/405 (77.0) CTPAs, including 13 new diagnoses of carcinoma.
Conclusions: We found that a low d-dimer score excluded all pulmonary embolisms, after a further specialist
panel review identified initial false positive reports. However, current evidence-based guidelines still recommend
that clinicians combine a d-dimer result with a validated clinical risk score when selecting suitable patients for
CTPA. This may result in better use of limited resources, prevent patients being exposed to unnecessary irradiation
and prevent potential complications as a result of iodinated contrast.
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Background
Pulmonary embolism (PE) is associated with substantial
morbidity and mortality. In the US more than 500 000
patients per year are diagnosed with pulmonary emboli,
resulting in approximately 200 000 deaths [1,2]. In
England and Wales there are around 65 000 cases of
pulmonary emboli annually amongst hospitalized
patients. The prevalence of unsuspected pulmonary
embolism at post-mortem is 3-8%, figures that have
changed little over three decades. The implication is
that the true number of cases may be substantially
higher than is currently being diagnosed [3].
The presentation, symptoms and clinical signs of pul-
monary embolism varies widely between patients [4].
Clinical suspicion invariably requires further investiga-
tion to confirm or exclude PE. In Scotland, computed
tomographic pulmonary angiography (CTPA) is increas-
ingly used as the first and only investigation for this
purpose [5]. This is because of greater availability and
reported overall sensitivity (89-100%) of helical CT, but
e x p o s e sp a t i e n t st os u b s t a n t i al ionizing radiation [6-8].
A recent review by Davies et al. found that iatrogenic
radiation exposure has significant risks which are often
overlooked, while it was estimated that 30% of com-
puted tomography tests may be unnecessary [9].
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and negative predictive value in most patients with sus-
pected thromboembolism, and may be an alternative first
investigation to CTPA [10]. D-dimers are degradation pro-
ducts of cross linked fibrin and are considered the best
laboratory markers of coagulation activation [11,12]. They
are commonly elevated in patients with recent surgery,
malignancy or infection [3,13]. As a result the diagnostic
value of d-dimer assays is higher for ambulatory patients
compared with those in hospital [14].
Our main aim was to assess the potential value of a
negative d-dimer assay to exclude pulmonary emboli
and reduce the number of performed CTPAs. A further
aim was to describe incidental but significant intrapul-
monary CTPA findings that may have accounted for
patients’ clinical presentations.
Results
A total of 416 CTPAs were performed during the study
period. 11/416 (2.6%) CTPAs were reported as indeter-
minate or inconclusive and excluded from further analy-
sis. ‘Technical factors’, for example inadequate contrast
opacification of the pulmonary arterial tree, were stated
as the reason for inconclusive studies. Of the remaining
405 CTPA studies, 226 (55.8%) were performed for
female and 179 (44.2%) for male patients. The mean age
of all patients was 63 years (range 20-95 and standard
deviation ± 17.2).
A diagnosis of pulmonary embolism was reported for
66 (16.3%) of the remaining 405 CTPAs. The expert
panel unanimously agreed that five (7.6%) of these were
false positive examinations. The positive predictive value
of CTPA for pulmonary embolism in this study was
92.4% (95% CI = 82.5%-97.2%).
The numbers of performed d-dimer assays, d-dimer
results and CTPAs positive for pulmonary embolism are
shown in Figure 1. Of the 216 (53.3%) patients who had a
d-dimer assay performed, 186 (86%) had a positive and
30 (14%) a negative d-dimer result. There were initially
two positive CTPAs with negative d-dimer results. Both
of these were unanimously judged to be negative CTPAs
(false positives) by the panel. The d-dimer assay’s nega-
tive predictive value was 93.3% (95% CI = 76.5%-98.8%)
based on the original number of positive CTPA reports
and 100% (95% CI = 85.9%-100%) based on the panel’s
review. The d-dimer assay and CTPA sensitivity, specifi-
city and predictive values are shown in Table 1. The
complete data set is available as an additional file 1 (see
CTPA ddimer.xls).
The main anatomical sites of pulmonary embolism are
shown in Table 2. Sub segmental embolisms were least
common, being described in 4 (6%) of cases. The main
findings of the CTPAs considered for analysis are shown in
Table 3. Significant non-PE intrapulmonary pathology was
reported for 312/405 (77.0) CTPAs. The most common
reported abnormalities were pleural effusion (16.5%),
bronchiectasis (10.6%) and consolidation (7.9%). There
were 13 (3.2) new diagnoses of unsuspected carcinoma. Of
the 66/405 (16.3) CTPAs reported as pulmonary embolism,
52 patients had significant additional pulmonary pathology.
Discussion
Main findings
The study’s main aim was to assess the potential value
o fan e g a t i v ed - d i m e ra s s a yt oe x c l u d ep u l m o n a r y
emboli and reduce the number of performed CTPAs.
We found a low (negative) d-dimer score to have a very
high negative predictive value, but that it did not
exclude all pulmonary emboli based on the initial CTPA
reports. However, a low d-dimer score did exclude all
pulmonary emboli after a further specialist panel review
identified false positive reports.
Comparison with existing literature
Our findings are comparable to other studies in various
health care settings. Dunn et al. reported a negative pre-
dictive value for d-dimer assay of 99.6% (95% CI = 98.7-
> 99.9%) and suggested that negative results could help
416 CTPAs performed 
during study period
405 remaining CTPAs
216 (53.3%) CTPAs with 
d-dimer assays
186 (86%) d-dimer tests 
>190 (positive)
39 CTPAs initially 
reported as PE positive
36 CTPAs PE positive 
after specialist review
30 (14%) d-dimer tests 
<190 (negative)
2 CTPAs initially reported 
as PE positive
0 CTPAs PE positive after 
specialist review
189(46.7%) CTPAs 
without d-dimer assays
25 CTPAs PE positive
11 Inconclusive or 
indeterminate CTPAs 
excluded from analysis
Figure 1 Number of computed tomography pulmonary
angiogram (CTPA) studies, d-dimer assays, and diagnoses of
pulmonary embolism (PE).
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recently, Eng et al. and Hirai et al. concluded that a d-
dimer test alone was suitable for screening patients with
a clinical suspicion of PE [16,17]. However, a number of
case reports have questioned whether a negative d-
dimer result alone is sufficient to exclude pulmonary
embolisms [18]. There is compelling evidence that a
negative d-dimer result can effectively exclude a PE
when it is combined with a low pretest clinical probabil-
ity score. Current best practice clinical guidance advises
combining the d-dimer result with a validated tool–for
example the Wells or Geneva rule–which allow risk to
be quantified in a structured manner [19-22].
A further study aim was to describe incidental but sig-
nificant intrapulmonary CTPA findings that may have
accounted for patients’ clinical presentations. Significant
pathological findings were reported for the vast majority
of CTPA studies. The number of CTPA reports which
described previously undiagnosed malignancies was sub-
stantially higher than reported by Kino et al. [23]. These
significant non-PE findings had clinical relevance for
some patients and may subconsciously lead clinicians to
rationalize CTPA requests. However, CTPA has certain
technical limitations that reduce its potential value in
assessing non-PE pathology and cannot be considered a
screening tool.
The anatomical distribution of pulmonary emboli we
found was comparable to that reported by Sohns et al.
[24]. The majority of thrombi were diffusely distributed
between the main pulmonary trunk, lobar and segmen-
tal arteries with only a small minority involving the sub-
segmental vessels. All of the false positive CTPAs were
initially reported as ‘small, sub-segmental pulmonary
embolism’. The expert panel’s opinion was that in these
cases small lymph nodes or veins adjacent to sub-seg-
mental arteries had typically been misinterpreted as fill-
ing defects. It is possible that a substantial number of
sub-segmental pulmonary emboli may be false positive
as a result of CTPAs being interpreted in a single plane.
Strengths and limitations
Our findings are based on a substantial sample and an
additional independent panel that reviewed CTPA stu-
dies to identify false positive results. We also identified
the anatomical distribution of emboli and additional
intrapulmonary pathology that may have accounted for
the patients’ symptoms. The study has a number of lim-
itations: CTPA findings were not linked with clinical
outcomes; validated tool such as the Geneva or Wells
rule was not used or recorded by clinicians requesting
CTPAs; other imaging, for example doppler ultrasound,
chest x-rays and ventilation perfusion scans were not
considered; and more modern alternatives to the 16-
slice CT scanner used in our study may have improved
diagnostic accuracy.
Implication and future research
There are clinical guidelines for health care workers
investigating a patient suspected of having a PE [19-22].
It is recommended that a clinical probability assessment
and d-dimer value should be combined and used to
quantify the patient’sr i s ko fP Ea sl o w ,m o d e r a t eo r
high. CTPAs are only indicated for those patients judged
to be at moderate or high risk. This approach is seldom
used in practice, resulting in unnecessary CTPAs being
performed. This is an inefficient use of limited time and
resources and expose patients to avoidable irradiation
and potential complications of iodinated contrast
[15,18]. Further research is required to better under-
stand the challenges in promoting and implementing
the routine use of clinical risk stratification for ambula-
tory patients with suspected PE.
Conclusions
A low d-dimer score had a very high negative predictive
value, but did not exclude all pulmonary embolisms
Table 1 D-dimer assay and CTPA sensitivity, specificity and predictive values (95% confidence intervals)
D-dimer assay:
Results based on number of positive CTPA results
CTPA
N = 41 (initial results) N = 36 (results after specialist review) N = 405
Sensitivity 95.1 (82.2-99.2) 100 (88.0-100) x
Specificity 16.0 (11.1-22.5) 16.7 (11.7-23.1) 98.5 (96.4-99.5)
Positive predictive value 21.0 (15.5-27.7) 19.4 (14.1-25.9) 92.4 (82.5-97.2)
Negative predictive value 93.3 (76.5-98.8) 100 (85.9-100) x
Table 2 Classification of pulmonary emboli according to
anatomical site
No* (%)
Large main trunk 21 (32)
Lobar artery 20 (30)
Segmental 21 (32)
Sub-segmental 4 (6)
Total 66 (100)
* Each PE positive case was included only once in the classification according
to the largest thrombosed vessel reported
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dimer score did exclude all pulmonary embolisms after
a further specialist panel review identified false positive
reports. A practical and evidence-based approach is to
combine a d-dimer result with a validated clinical risk
score to help select suitable patients for CTPA. This
may result in better use of limited resources, prevent
patients being exposed to unnecessary irradiation and
prevent potential complications as a result of iodinated
contrast.
Availability of supporting data
The data set supporting the results of this article is
included within the article and its additional file 1.
Methods
All CTPAs that had been performed at a District General
Hospital (DGH) in Lanarkshire, Scotland, in the fourteen
month period from 1
st June 2008 to 31
st July 2009 were
identified and retrospectively reviewed on the Hospital
Information System (HIS). This sample included CTPAs
requested for hospitalized and ambulatory patients.
Patients were considered ambulatory if they had been
referred from the accident and emergency department or
from medical, surgical and oncology out-patient units.
An indeterminate or inconclusive CTPA report was the
only exclusion criterion.
All PE positive studies were reviewed independently by
a panel consisting of three radiologists with an interest in
this area who interpreted the CTPAs using axial, coronal
and sagittal reformats. The initial CTPA reports were
judged to be false positive only if all three panel members
agreed that the study did not show sufficient evidence of
PE. Data were collected for presence or absence of PE
and the type of PE, whether a d-dimer assay was per-
formed and the d-dimer result if applicable. Patients’ age
and gender and other reported pathological intra thoracic
findings were also collected. Patient identifiers were
removed and data were entered in an Excel spreadsheet.
The data were exported to SPSS version 17.0 for calcula-
tion of descriptive statistics.
The d-dimer assay and CTPA sensitivity, specificity
and positive and negative predictive values were calcu-
lated with 95% confidence intervals. The d-dimer assay
values were calculated twice, using the initial number of
positive CTPA results, and then the revised number of
positive CTPA results as determined by the specialist
panel. Pulmonary emboli were classified according to
their anatomical distribution. Each case was included
only once and grouped according to the largest throm-
bosed vessel reported.
CTPA
All CTPA studies were performed using a Toshiba
Aquillon 16 slice CT scanner with slice thickness set at
1 mL.
D-dimer
Four different types of d-dimer assay formats are cur-
rently available: enzyme linked immunosorbent assay
(ELISA), whole blood erythrocyte agglutination assay
(SimpliRED), semiquantitative latex agglutination assays
(Accuclot, Trinity Biotech, Bray) and immunochromato-
graphic/quantitative immunoturbidimetric assays. ELISA
is considered the gold standard for the determination of
d-dimer concentration. It is a highly sensitive test but is
time consuming and not suitable for individual patient
testing. The Accuclot d-dimer assay is less sensitive, but
Table 3 The main findings of 405 CTPAs performed between 01/06/2008 and 31/07/2009 that met inclusion criteria
Main CTPA finding No (%)* No (%)*
No pathology 103 (25.4)
Pulmonary embolism (PE) 66 (16.3)
￿ PE only 14 (3.5)
￿ PE with additional abnormal finding (included below) 52 (12.8)
Significant non-PE intrapulmonary pathology 312 (77.0)
￿ Pleural effusion 67 (16.5)
￿ Consolidation 32 (7.9)
￿ Effusion and consolidation 27 (6.7)
￿ Carcinoma 13 (3.2)
￿ Lobar collapse 22 (5.4)
￿ Lymphadenopathy 13 (3.2)
￿ Bronchiectasis 43 (10.6)
￿ Pulmonary fibrosis 7 (1.7)
￿ Other (for example atelectasis) 88 (21.7)
*Some CTPAs had more than one main finding reported. The number and percentage is the proportion of the 405 CTPAs with that specific finding
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Amax Accuclot d-dimer assay–a semi quantitative latex
agglutination assay–was used during the study period. A
d-dimer value ≥190 ng/mL was considered positive
(high) and < 190 ng/mL negative (low) in accordance
with local guidelines and the recommendation of the
Accuclot d-dimer assay manufacturer.
Additional material
Additional file 1: The complete data set is available as a Microsoft
Excel spreadsheet and can be downloaded as an additional file
(CTPA ddimer.xls).
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